Skip to main content
JINZI HAM CO.,LTD. logo

JINZI HAM CO.,LTD. — Investor Relations & Filings

Ticker · 002515 ISIN · CNE100000XR1 LEI · 300300VVE97TSPV9T045 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,983 across all filing types
Latest filing 2018-01-30 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002515

About JINZI HAM CO.,LTD.

https://www.jinzichina.com

JINZI HAM CO.,LTD. specializes in the production, processing, and distribution of traditional dry-cured meat products, with a primary focus on Jinhua ham. The company utilizes traditional fermentation and curing techniques combined with modern food processing technology to produce a diverse range of products, including hams, sausages, bacon, and sauce-marinated meats. In addition to its core meat business, the company has expanded into the development of plant-based protein products, leveraging research and development to meet evolving consumer preferences. Its operations emphasize quality control and food safety throughout the supply chain, catering to both domestic and international markets. The company's product portfolio is characterized by its adherence to geographical indication standards for Jinhua ham, ensuring authentic flavor profiles and high nutritional value.

Recent filings

Filing Released Lang Actions
关于控股子公司（中钰资本）转让北京新皓然软件技术有限责任公司10%股权的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the transfer of a 10% equity stake in a subsidiary company (Beijing Xin Haoran Software Technology Co., Ltd.) by the controlling subsidiary Zhongyu Capital to another company. It details the transaction overview, parties involved, financial data of the target company, transaction pricing, and the impact on the company. There is no indication that this is a full financial report, audit report, or earnings release. It is a corporate announcement about a capital transaction involving equity transfer. This fits best under Capital/Financing Update (CAP) as it relates to changes in the company's capital investments and financing activities.
2018-01-30 Chinese
2017年度业绩预告修正公告
Regulatory Filings Classification · 95% confidence The document is titled as a "2017年度业绩预告修正公告" which translates to "2017 Annual Performance Forecast Revision Announcement." It discusses the revision of the company's expected net profit for the fiscal year 2017, reasons for the revision, and notes that the revised forecast is based on preliminary estimates and has not been audited. It explicitly states that detailed financial data will be disclosed in the 2017 Annual Report. The document is relatively short (2493 characters) and serves as an announcement updating investors on the revised earnings forecast rather than providing full financial statements or comprehensive analysis. Therefore, it is not an Annual Report (10-K) or Interim Report (IR), but rather a regulatory announcement about earnings forecast revision. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-01-30 Chinese
关于下属子公司（瑞一科技）拟对大道隆达（北京）医药科技发展有限公司增资的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding a subsidiary's planned capital increase investment in another company. It includes specifics about the investment amount, shareholder structure, board approval, and the strategic rationale behind the investment. The document is issued by the company's board and contains no financial statements or quarterly/yearly financial results. It is not an earnings release, annual report, or interim report. It is not a call transcript or a legal proceeding update. The document is a formal announcement of a capital investment transaction by a subsidiary, which fits the category of Capital/Financing Update (CAP). The document length (6161 characters) and detailed content support this classification rather than a brief announcement or a regulatory filing fallback.
2018-01-30 Chinese
关于下属子公司购买银行理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by 金字火腿股份有限公司 regarding the progress of its subsidiaries purchasing bank wealth management products. It details authorization from the board, specifics of the financial products purchased, risk disclosures, and internal controls. There are no financial statements, no quarterly or annual results, no management discussion of financial results, no voting results, no legal proceedings, no merger or acquisition activity, and no executive changes. The document is a regulatory announcement about investment activities and risk disclosures related to the company's use of idle funds in bank wealth management products. It is not a financial report or earnings release but an update on financing/investment activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is sufficient and contains substantive content about financing activities, not just a brief notice or report publication announcement.
2018-01-24 Chinese
关于控股子公司（中钰资本）拟投资设立全资子公司（中钰国际）的公告
Capital/Financing Update Classification · 95% confidence The document is a company announcement regarding the establishment of a wholly-owned subsidiary by a controlling subsidiary. It includes details about the investment, board approval, and the purpose and impact of the investment. The document is short (1215 characters) and does not contain financial statements or detailed financial data. It is an announcement of a corporate action related to investment and subsidiary formation, not a full financial report or detailed management discussion. It also includes a board resolution reference but does not announce changes in board members or senior management. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to investment and capital structure changes through subsidiary establishment.
2018-01-19 Chinese
关于控股子公司（中钰资本）拟投资设立九洲中钰医药产业投资基金（有限合伙）的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 金字火腿股份有限公司 regarding its controlling subsidiary's planned investment to establish a pharmaceutical industry investment fund. It details the investment amount, parties involved, board approval, risk factors, and the framework agreement. The content focuses on a capital investment and financing activity rather than a financial report, earnings release, or management discussion. There is no financial statement or quarterly/yearly report data. The document is a formal announcement of a financing/investment transaction, fitting the Capital/Financing Update category.
2018-01-19 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.